The AllTrials campaign is an initiative of Bad Science, BMJ, Centre for Evidence-based Medicine, Cochrane Collaboration, James Lind Initiative, PLOS and Sense About Science and is being led in the US by Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice.
The AllTrials campaign was launched in January 2013 and calls for all past and present clinical trials to be registered and their results reported. The campaign has published a detailed plan on how all clinical trials can be registered and all results reported. You can download the PDF or read it online.
November 2019 - signatures to the petition stand at 94,791
September 25 2013
AllTrials has released a campaign for all past trials that were not registered to be registered retrospectively.
August 5 2013
The AllTrials campaign has released a detailed plan on how all clinical trials can be registered and reported. This plan has released actions on behalf of regulators, researchers, funders and publishers and socities. Please click here to read more about the plan.
May 4 2013
Public support for the AllTrials campaign continues to grow. Individual signatures to the petition are nearing the significant milestone of 50,000, along with new research institutions and healthcare organizations daily.
GSK have announced that the company has signed up to the AllTrials campaign for clinical trial transparency. GSK have also stated that they will disclose clinical trial results and reports once they have been approved or discontinued from development and the results have been published.